MorphoSys AG MOR

$ 18.96 2.43%

Annual report 2023
added 12-21-2024

MorphoSys AG Balance Sheet 2011-2024 | MOR

Annual Balance Sheet MorphoSys AG

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	163 M	-1.74 M	268 M	8.9 M	-5.07 M	6.08 M	81 M	127 M	38.1 M	-54.5 M
Long Term Debt	-	-	-	273 M	-	71.5 K	87.8 K	218 K	225 K	252 K	299 K	73.6 K	73.6 K
Long Term Debt Current	3.63 M	7.56 M	3.24 M	3.06 M	2.03 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	40.2 M	4.47 M	9.03 M	9.84 M	9.87 M	45 M	60.1 M	6.63 M	7.52 M
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	1.98 B	2.24 B	2.31 B	1.04 B	102 M	50.4 M	56.7 M	48.1 M	37.3 M	77.7 M	95.5 M	22.3 M	31.3 M
Deferred Revenue	-	-	-	86.5 M	1.57 M	794 K	1.39 M	1.23 M	1.99 M	14.1 M	15.3 M	628 K	-
Retained Earnings	-	-	-	-158 M	-256 M	-153 M	-97.4 M	-27.5 M	32.8 M	17.9 M	20.9 M	7.62 M	5.68 M
Total Assets	2.03 B	2.4 B	2.56 B	1.66 B	496 M	539 M	415 M	464 M	400 M	426 M	448 M	224 M	228 M
Cash and Cash Equivalents	158 M	402 M	123 M	110 M	44.3 M	45.5 M	76.6 M	73.9 M	-	-	-	-	-
Book Value	49 M	157 M	245 M	621 M	395 M	488 M	359 M	415 M	363 M	349 M	352 M	202 M	197 M
Total Shareholders Equity	-	-	-	621 M	395 M	488 M	359 M	415 M	-	-	-	-	-

All numbers in EUR currency

Quarterly Balance Sheet MorphoSys AG

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	39.3 M	-	-	-	42 M	-	-	-	40 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	2.03 B	-	-	-	838 M	-	-	-	40.2 M	-	-	-	4.47 M	-	-	-	9.03 M	-	-	-	9.84 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	2.31 B	-	-	-	1.04 B	-	-	-	102 M	-	-	-	50.4 M	-	-	-	56.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-672 M	-	-	-	-158 M	-	-	-	-256 M	-	-	-	-153 M	-	-	-	-97.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	2.56 B	-	-	-	1.66 B	-	-	-	496 M	-	-	-	539 M	-	-	-	415 M	-	-	-	464 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	123 M	-	-	-	110 M	-	-	-	44.3 M	-	-	-	45.5 M	-	-	-	76.6 M	-	-	-	73.9 M	-	-	-	90.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	245 M	-	-	-	621 M	-	-	-	395 M	-	-	-	488 M	-	-	-	359 M	-	-	-	464 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	245 M	-	-	-	621 M	-	-	-	395 M	-	-	-	488 M	-	-	-	360 M	-	-	-	415 M	-	-	-	363 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency